NCT06143748 2025-09-17
EC-CRT-006
Sun Yat-sen University
Phase 2 Active not recruiting
Clinical Trials
15 trialsNCT06601309 2025-09-15
ESCC
Fujian Medical University Union Hospital
Phase 2 Recruiting
NCT07055841 2025-07-09
Single-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Shandong Tumor Hospital
Phase 2 Recruiting
NCT06713057 2024-12-03
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
West China Hospital
Phase 2 Not yet recruiting
NCT05520619 2024-11-18
EC-CRT-002
Sun Yat-sen University
Phase 2 Active not recruiting
NCT06588335 2024-09-19
BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital
Phase 2 Not yet recruiting
NCT06532539 2024-08-01
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT04005170 2022-08-23
Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT04625543 2022-04-26
Neoadjuvant Immunotherapy to ESCC
Qilu Hospital of Shandong University
Phase 2 Withdrawn
NCT00582205 2021-05-19
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
University of Oklahoma
Phase 2 Terminated
NCT04499118 2020-08-05
AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer
Sichuan Provincial People's Hospital
Phase 2 Unknown
NCT04006041 2019-12-26
Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT03927495 2019-05-29
KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Phase 2 Unknown
NCT00933387 2016-05-04
A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
National Health Research Institutes, Taiwan
Phase 2 Completed
NCT00818090 2013-04-12
Paclitaxel and Cisplatin for Thymic Neoplasm
Korean Cancer Study Group
Phase 2 Terminated